SCHEDULE 13G/A: TPG Entities Report Full Divestment of Progyny, Inc. Stake

TPG GP A, LLC, along with James G. Coulter and Jon Winkelried, have reported zero beneficial ownership in Progyny, Inc., signaling a complete exit from their investment.

Summary

• TPG GP A, LLC, James G. Coulter, and Jon Winkelried, previously deemed beneficial owners of Progyny, Inc. common stock, now report 0.00 shares beneficially owned.
• This Schedule 13G Amendment No. 6 indicates that the reporting persons no longer hold a reportable stake in Progyny, Inc.
• The event requiring this filing, which led to the change in beneficial ownership, occurred on March 31, 2025.

Sentiment

Score: 3

Explanation: The complete divestment by a significant institutional investor like TPG-related entities is generally perceived as a negative signal for the company, potentially indicating a lack of confidence or a strategic shift by the investor.

Negatives

• The complete divestment of shares by TPG-related entities, a significant institutional investor, could be perceived negatively by the market, potentially signaling a lack of confidence in Progyny, Inc.

Future Outlook

NA

Management Comments

• Messrs. Coulter and Winkelried disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein, if any.

Industry Context

This filing primarily reflects a change in an institutional investor's portfolio allocation rather than a direct commentary on broader industry trends within the healthcare or fertility sector. However, a major investor's exit could prompt market speculation regarding the company's prospects within its industry.

Stakeholder Impact

• Shareholders: May react negatively to the news of a major institutional investor exiting, potentially leading to downward pressure on the stock price due to perceived loss of institutional confidence.

Key Dates

Recommendation

Keywords

Progyny, TPG, SEC filing, Schedule 13G, beneficial ownership, divestment, institutional investor, common stock